Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREACT: Preoperative Radiochemotherapy vs Chemotherapy in Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
NCT03013010Phase 3Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Dec 2016
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur-gimeracil-oteracil, oxaliplatin in gastric adenocarcinoma, esophagogastric junction adenocarcinoma (GEJA), sponsored by Fudan University Shanghai Cancer Center. Started Dec 2016; status: completed.
02
Drugs
tegafur-gimeracil-oteraciloxaliplatin
03
Conditions
gastric adenocarcinomaesophagogastric junction adenocarcinoma (GEJA)
Beyond the preview
Go deeper on NCT03013010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013010.